China Psoriasis Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Psoriasis Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Psoriasis Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Psoriasis Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas Pharma Inc

    • Merck & Co, Inc

    • Biocon Limited

    • F Hofffmann-La Roche

    • Boehringer Ingelheim GmbH

    • GlaxoSmithKline plc

    • Valeant Pharmaceuticals International, Inc

    • G & W Laboratories Inc

    • AstraZeneca plc

    • Eli Lilly and Company

    By Type:

    • Oral

    • Parenteral

    • Topical

    By End-User:

    • TNF Inhibitors

    • PDE4 Inhibitors

    • Interleukin Blockers

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriasis Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Psoriasis Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027

    • 1.3.2 China Psoriasis Therapeutics Market Size and Growth Rate of Parenteral from 2016 to 2027

    • 1.3.3 China Psoriasis Therapeutics Market Size and Growth Rate of Topical from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Psoriasis Therapeutics Market Size and Growth Rate of TNF Inhibitors from 2016 to 2027

    • 1.4.2 China Psoriasis Therapeutics Market Size and Growth Rate of PDE4 Inhibitors from 2016 to 2027

    • 1.4.3 China Psoriasis Therapeutics Market Size and Growth Rate of Interleukin Blockers from 2016 to 2027

    • 1.4.4 China Psoriasis Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Psoriasis Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Psoriasis Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Oral

    • 3.4.2 Market Size and Growth Rate of Parenteral

    • 3.4.3 Market Size and Growth Rate of Topical

    4 Segmentation of Psoriasis Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Psoriasis Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Psoriasis Therapeutics in TNF Inhibitors

    • 4.4.2 Market Size and Growth Rate of Psoriasis Therapeutics in PDE4 Inhibitors

    • 4.4.3 Market Size and Growth Rate of Psoriasis Therapeutics in Interleukin Blockers

    • 4.4.4 Market Size and Growth Rate of Psoriasis Therapeutics in Others

    5 Market Analysis by Regions

    • 5.1 China Psoriasis Therapeutics Production Analysis by Regions

    • 5.2 China Psoriasis Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Psoriasis Therapeutics Landscape Analysis

    • 6.1 North China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 6.2 North China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    7 Central China Psoriasis Therapeutics Landscape Analysis

    • 7.1 Central China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 7.2 Central China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    8 South China Psoriasis Therapeutics Landscape Analysis

    • 8.1 South China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 8.2 South China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    9 East China Psoriasis Therapeutics Landscape Analysis

    • 9.1 East China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 9.2 East China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    10 Northeast China Psoriasis Therapeutics Landscape Analysis

    • 10.1 Northeast China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 10.2 Northeast China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    11 Southwest China Psoriasis Therapeutics Landscape Analysis

    • 11.1 Southwest China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 11.2 Southwest China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    12 Northwest China Psoriasis Therapeutics Landscape Analysis

    • 12.1 Northwest China Psoriasis Therapeutics Landscape Analysis by Major Types

    • 12.2 Northwest China Psoriasis Therapeutics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Astellas Pharma Inc

      • 13.1.1 Astellas Pharma Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck & Co, Inc

      • 13.2.1 Merck & Co, Inc Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Biocon Limited

      • 13.3.1 Biocon Limited Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 F Hofffmann-La Roche

      • 13.4.1 F Hofffmann-La Roche Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Boehringer Ingelheim GmbH

      • 13.5.1 Boehringer Ingelheim GmbH Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 GlaxoSmithKline plc

      • 13.6.1 GlaxoSmithKline plc Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Valeant Pharmaceuticals International, Inc

      • 13.7.1 Valeant Pharmaceuticals International, Inc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 G & W Laboratories Inc

      • 13.8.1 G & W Laboratories Inc Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 AstraZeneca plc

      • 13.9.1 AstraZeneca plc Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Eli Lilly and Company

      • 13.10.1 Eli Lilly and Company Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of Parenteral from 2016 to 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of Topical from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of TNF Inhibitors from 2016 to 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of PDE4 Inhibitors from 2016 to 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of Interleukin Blockers from 2016 to 2027

    • Figure China Psoriasis Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Psoriasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Psoriasis Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Psoriasis Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Psoriasis Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Psoriasis Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Parenteral

    • Figure Market Size and Growth Rate of Topical

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Psoriasis Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Psoriasis Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of TNF Inhibitors

    • Figure Market Size and Growth Rate of PDE4 Inhibitors

    • Figure Market Size and Growth Rate of Interleukin Blockers

    • Figure Market Size and Growth Rate of Others

    • Table China Psoriasis Therapeutics Production by Regions

    • Table China Psoriasis Therapeutics Production Share by Regions

    • Figure China Psoriasis Therapeutics Production Share by Regions in 2016

    • Figure China Psoriasis Therapeutics Production Share by Regions in 2021

    • Figure China Psoriasis Therapeutics Production Share by Regions in 2027

    • Table China Psoriasis Therapeutics Consumption by Regions

    • Table China Psoriasis Therapeutics Consumption Share by Regions

    • Figure China Psoriasis Therapeutics Consumption Share by Regions in 2016

    • Figure China Psoriasis Therapeutics Consumption Share by Regions in 2021

    • Figure China Psoriasis Therapeutics Consumption Share by Regions in 2027

    • Table North China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table North China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure North China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure North China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure North China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table North China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table North China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure North China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure North China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table Central China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table Central China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Central China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure Central China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure Central China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table Central China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Central China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure Central China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure Central China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table South China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table South China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure South China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure South China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table South China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure South China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure South China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table East China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table East China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure East China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure East China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure East China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table East China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table East China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure East China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure East China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table Northeast China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table Southwest China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table Southwest China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table Southwest China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure Southwest China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table Northwest China Psoriasis Therapeutics Consumption by Types from 2016 to 2027

    • Table Northwest China Psoriasis Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by Types in 2016

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by Types in 2021

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by Types in 2027

    • Table Northwest China Psoriasis Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Psoriasis Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by End-Users in 2016

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by End-Users in 2021

    • Figure Northwest China Psoriasis Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Merck & Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc

    • Table Product and Service Introduction of Merck & Co, Inc

    • Table Company Profile and Development Status of Biocon Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon Limited

    • Figure Sales and Growth Rate Analysis of Biocon Limited

    • Figure Revenue and Market Share Analysis of Biocon Limited

    • Table Product and Service Introduction of Biocon Limited

    • Table Company Profile and Development Status of F Hofffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hofffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hofffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hofffmann-La Roche

    • Table Product and Service Introduction of F Hofffmann-La Roche

    • Table Company Profile and Development Status of Boehringer Ingelheim GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH

    • Table Product and Service Introduction of Boehringer Ingelheim GmbH

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International, Inc

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International, Inc

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International, Inc

    • Table Product and Service Introduction of Valeant Pharmaceuticals International, Inc

    • Table Company Profile and Development Status of G & W Laboratories Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of G & W Laboratories Inc

    • Figure Sales and Growth Rate Analysis of G & W Laboratories Inc

    • Figure Revenue and Market Share Analysis of G & W Laboratories Inc

    • Table Product and Service Introduction of G & W Laboratories Inc

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.